HEPA
Hepion Pharmaceuticals, Inc. · Healthcare · Market cap $10.7M
Insiders bought $835K net in the last 90 days ·0 sellers, 6 buyers· latest Form 4 filed Oct 2, 2026
Insider Buying
$1.2M
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Latest filing
Oct 2, 2026
Fisher Danina
Hepion Pharmaceuticals, Inc. (HEPA) has 10 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Oct 2, 2026.
Inside the rolling window, 6 insiders at Hepion Pharmaceuticals, Inc. reported 10 open-market purchases totaling $1.2M and no open-market sales. Insiders have net bought $1.2M over the trailing 6 months. The most recent open-market filing is a purchase of 200,000 shares by Director Fisher Danina, dated Sep 29, 2026, worth $10K.
- Industry:Biotechnology
- CEO:Gary S. Stetz
- Employees:2
- HQ:Morristown, NJ, US
- IPO:2014-02-10
| Source | |||||||
|---|---|---|---|---|---|---|---|
Fisher DaninaFirst filing | Director | Purchase | 200,000 | $10K | Oct 2 | +46.9% | SEC ↗ |
Stetz Gary S. IIFirst filing | Director | Purchase | 500,000 | $25K | Aug 13 | +70.0% | SEC ↗ |
| Interim CEO | Purchase | 2,000,000 | $100K | Aug 13 | +70.0% | SEC ↗ | |
Purcell Michael J.First in 4 months | Director | Purchase | 2,000,000 | $100K | Aug 13 | +70.0% | SEC ↗ |
Appajosyula SireeshFirst in 4 months | Chief Operating Officer | Purchase | 2,000,000 | $100K | Aug 13 | +70.0% | SEC ↗ |
LoPriore Vincent SFirst in 4 months | Executive Chairman | Purchase | 10,000,000 | $500K | Aug 13 | +70.0% | SEC ↗ |
Purcell Michael J.First filing | Director | Purchase | 1,250,000 | $50K | Apr 27 | +91.9% | SEC ↗ |
LoPriore Vincent SFirst filing | Executive Chairman | Purchase | 6,250,000 | $250K | Apr 27 | +91.9% | SEC ↗ |
Appajosyula SireeshFirst filing | Director | Purchase | 1,250,000 | $50K | Apr 27 | — | SEC ↗ |
Stetz Gary S.First filing | Interim CEO | Purchase | 1,250,000 | $50K | Apr 27 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does HEPA have?
Hepion Pharmaceuticals, Inc. (HEPA) has 10 SEC Form 4 filings (12 transaction rows) in the rolling 365-day window, disclosed by 6 distinct insiders. Most recent filing: Oct 2, 2026.
When was the most recent SEC Form 4 filing for HEPA?
The most recent Form 4 filing for HEPA on Tracefour is dated Oct 2, 2026.
What is the net insider flow at HEPA over the last 6 months?
Over the trailing 180 days, insiders at HEPA have net bought $1.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at HEPA in the current window?
Inside the rolling window, insiders at HEPA bought $1.2M and sold $0 based on SEC Form 4 filings.
Can I get alerts for HEPA insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Hepion Pharmaceuticals, Inc. (HEPA). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Hepion Pharmaceuticals, Inc. is in the Healthcare sector.